Table 6.
Tumor control probability results in nominal PB‐PB, PB‐MC, and MC‐MC plans of breast cancer. The results are averaged over ten breast cancer patients.
|
PB‐PB Avg. (±SD) |
PB‐MC Avg. (±SD) |
P‐value |
MC‐MC Avg. (±SD) |
P‐value | ||
|---|---|---|---|---|---|---|
| CTV_Total | TCP (%) | 93.2 (±0.6) | 91.4 (±0.7) | <0.001 | 92.9 (±0.6) | 0.345 |
| CTV_CW/Breast | TCP (%) | 92.9 (±0.9) | 91.2 (±1.2) | 0.002 | 92.7 (±0.7) | 0.535 |
| CTV_AxI | TCP (%) | 93.4 (±0.5) | 91.5 (±1.0) | <0.001 | 93.2 (±0.6) | 0.545 |
| CTV_AxII | TCP (%) | 93.3 (±0.7) | 91.8 (±0.9) | 0.002 | 93.1 (±0.7) | 0.571 |
| CTV_AxIII | TCP (%) | 93.4 (±0.5) | 91.7 (±0.9) | 0.001 | 93.1 (±0.6) | 0.326 |
| CTV_IMN | TCP (%) | 93.0 (±1.3) | 90.2 (±2.1) | 0.003 | 92.9 (±1.4) | 0.940 |
| CTV_SCVN | TCP (%) | 93.4 (±0.7) | 90.5 (±1.2) | <0.001 | 93.1 (±0.7) | 0.385 |
PB‐PB, PB optimization followed by PB dose calculation; PB‐MC, PB optimization followed by MC dose calculation; MC‐MC, MC optimization followed by MC dose calculation; CW, chestwall; EUD, equivalent uniform dose; IMN, internal mammary nodes; SCVN, supraclavicular nodes; TCP, tumor control probability.
P‐value for PB‐MC vs. PB‐PB.
P‐value for MC‐MC vs. PB‐PB.